ConductScience.org, home

Paper18077828

Genetic variations and treatments that affect the lifespan of the NPC1 mouse.

Liu B and 4 others. J Lipid Res, 2008. Cited by 134 papers, by iCite.

Cite this record

ConductScience Library. Genetic variations and treatments that affect the lifespan of the NPC1 mouse. Papers, record 18077828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18077828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic variations and treatments that affect the lifespan of the NPC1 mouse.
PubMed
Journal
J Lipid Res
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
134
iCite
Relative citation ratio, by iCite
3.3
iCite
Revised in PubMed
2021-12-03
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu BBenny
2Li HHao
3Repa JJJoyce J
4Turley SDStephen D
5Dietschy JMJohn M

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA-Binding ProteinsMajor topic
Genetic VariationMajor topic
LongevityMajor topic
ProteinsMajor topic
Receptors, Cytoplasmic and NuclearMajor topic
SialyltransferasesMajor topic
Animals
Cyclodextrins
Gene Deletion
Intracellular Signaling Peptides and Proteins
Liver X Receptors
Mice
Mice, Knockout
Neurodegenerative Diseases
Niemann-Pick C1 Protein
Niemann-Pick Diseases
Orphan Nuclear Receptors
Pregnanolone
Treatment Outcome

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL-09610NHLBI NIH HHSUnited StatesR01HL009610PubMed and NIHNIH RePORTER
T32 DK-07745NIDDK NIH HHSUnited StatesT32DK007745PubMed and NIHNIH RePORTER

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02912793Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C PatientsBackgroundClinicalTrials.gov
NCT02939547Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)BackgroundClinicalTrials.gov

Download CSV of trials

Cited by92

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 134 citations.

PMIDTitleJournalYearIn PapersSource
41260183Utility of 24(S)-hydroxycholesterol as a proximal biomarker to monitor long-term intrathecal adrabetadex therapy in individuals with Niemann-Pick disease, type C1.Mol Genet Metab2025https://conductscience.org/library/papers/41260183PubMed
37942865Neuro-HIV-New insights into pathogenesis and emerging therapeutic targets.FASEB J2023https://conductscience.org/library/papers/37942865PubMed
37670901
Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial.
Mol Genet Metab Rep2023https://conductscience.org/library/papers/37670901PubMed
37567876Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine.NPJ Genom Med2023https://conductscience.org/library/papers/37567876PubMed
37407594The cholesterol transporter NPC1 is essential for epigenetic regulation and maturation of oligodendrocyte lineage cells.Nat Commun2023https://conductscience.org/library/papers/37407594PubMed
36979508Grafting of Cyclodextrin to Theranostic Nanoparticles Improves Blood-Brain Barrier Model Crossing.Biomolecules2023https://conductscience.org/library/papers/36979508PubMed
36971991Lysosomal cholesterol accumulation is commonly found in most peroxisomal disorders and reversed by 2-hydroxypropyl-β-cyclodextrin.Sci China Life Sci2023https://conductscience.org/library/papers/36971991PubMed
36721240Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.Biomark Res2023https://conductscience.org/library/papers/36721240PubMed
36614015Organ Weights in NPC1 Mutant Mice Partly Normalized by Various Pharmacological Treatment Approaches.Int J Mol Sci2022https://conductscience.org/library/papers/36614015PubMed
36559052Cyclodextrins: Only Pharmaceutical Excipients or Full-Fledged Drug Candidates?Pharmaceutics2022https://conductscience.org/library/papers/36559052PubMed
36542657Traits, phylogeny and host cell receptors predict Ebolavirus host status among African mammals.PLoS Negl Trop Dis2022https://conductscience.org/library/papers/36542657PubMed
35140266Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression.Sci Rep2022https://conductscience.org/library/papers/35140266PubMed
34445564Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives.Int J Mol Sci2021https://conductscience.org/library/papers/34445564PubMed
34296265Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics.Hum Mol Genet2021https://conductscience.org/library/papers/34296265PubMed
34202978Neurodegeneration in Niemann-Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment.Int J Mol Sci2021https://conductscience.org/library/papers/34202978PubMed
34113546A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1.Mol Genet Metab Rep2021https://conductscience.org/library/papers/34113546PubMed
33878344Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C.Dev Cell2021https://conductscience.org/library/papers/33878344PubMed
33802605Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.Int J Mol Sci2021https://conductscience.org/library/papers/33802605PubMed
33256121Understanding and Treating Niemann-Pick Type C Disease: Models Matter.Int J Mol Sci2020https://conductscience.org/library/papers/33256121PubMed
32890578Delineation of metabolic responses of Npc1-/-nih mice lacking the cholesterol-esterifying enzyme SOAT2 to acute treatment with 2-hydroxypropyl-β-cyclodextrin.Steroids2020https://conductscience.org/library/papers/32890578PubMed

See all 92 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18077828

GET https://conductscience.org/api/papers/v1/18077828/cited_by?page=2